Showing results (41-50 of 2,902) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|August 12, 2017
Association of long non-coding RNA H19 and microRNA-21 expression with the biological features and prognosis of non-small cell lung cancerY Zhou, B Sheng, Q Xia, et al.Cancer Gene Therapy|August 5, 2017
FBXO4 inhibits lung cancer cell survival by targeting Mcl-1 for degradationC Feng, F Yang, J WangCancer Gene Therapy|April 16, 2016
Enhanced antitumor effect of combining TRAIL and MnSOD mediated by CEA-controlled oncolytic adenovirus in lung cancerR Zhang, X Zhang, B Ma, et al.Cancer Gene Therapy|April 16, 2016
Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic deliveryS C Katz, G R Point, M Cunetta, et al.Cancer Gene Therapy|March 19, 2016
Precise and efficient siRNA design: a key point in competent gene silencingE Fakhr, F Zare, L Teimoori-ToolabiCancer Gene Therapy|July 22, 2022
ARID2 suppression promotes tumor progression and upregulates cytokeratin 8, 18 and β-4 integrin expression in TP53-mutated tobacco-related oral cancer and has prognostic implicationsPallavi Shukla, Prerana Dange, Bhabani Shankar Mohanty, et al.Cancer Gene Therapy|July 22, 2022
Gastrointestinal cancer-associated fibroblasts expressing Junctional Adhesion Molecule-A are amenable to infection by oncolytic reovirusTom J Harryvan, Matteo Golo, Nicole Dam, et al.Cancer Gene Therapy|July 21, 2022
CpG-binding protein CFP1 promotes ovarian cancer cell proliferation by regulating BST2 transcriptionLiu-Qing Yang, Han-Yin Hu, Yao Han, et al.Cancer Gene Therapy|July 28, 2022
Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent mannerMichelle L Woods, Astrid Weiss, Anna M Sokol, et al.Cancer Gene Therapy|June 22, 2018
miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cellsDan Yue, Xiaosong QinPageof 291